Company: HBCP
Filing Date: 2025-11-21
Form Type: S-3
Source: 0001628280-25-053512
Chunk: 24

Company: HOME BANCORP, INC.
Filing Date: 2025-11-21
Form: S-3
Chunk 24
---
 with the subordinated debt securities, (2) any such indebtedness, obligation or liability which is subordinated to indebtedness of Home Bancorp to substantially the same extent as or to a greater extent than the subordinated debt securities are subordinated, (3) any indebtedness to a subsidiary of Home Bancorp and (4) the subordinated debt securities.

The subordinated indenture does not limit or prohibit the incurrence of additional senior debt, which may include indebtedness that is senior to the subordinated debt securities, but subordinate to our other obligations. Any prospectus supplement relating to a particular series of subordinated debt securities will set forth the aggregate amount of our indebtedness senior to the subordinated debt securities as of a recent practicable date.

The prospectus supplement may further describe the provisions, if any, which may apply to the subordination of the subordinated debt securities of a particular series.

#### Restrictive Covenants
The indentures do not contain any significant restrictive covenants. The prospectus supplement relating to a series of senior or subordinated debt securities may describe certain restrictive covenants, if any, to which we may be bound under the applicable indenture.

#### Governing Law
Unless indicated otherwise in the applicable prospectus supplement, the indentures and the debt securities will be governed by, and construed in accordance with, the laws of the State of New York.

### DESCRIPTION OF COMMON STOCK AND PREFERRED STOCK
Home Bancorp’s authorized capital stock consists of:

• 40,000,000 shares of common stock, $0.01 par value per share; and

• 10,000,000 shares of special preferred stock, $0.01 par value per share.

As of September 30, 2025, 7,827,481 shares of our common stock were issued and outstanding and no shares of preferred stock outstanding. Also, as of September 30, 2025, there were outstanding stock options to purchase 79,946 shares of our common stock and 117,694 shares of unvested restricted stock grants of our common stock held by our employees, officers and directors. We have also reserved an additional 278,664 shares for issuance in connection with share-based payment awards that may be granted under our 2021 Equity Incentive Plan.

In this section we describe certain features and rights of our capital stock. The summary does not purport to be exhaustive and is qualified in its entirety by reference to the Company’s articles of incorporation and bylaws